arginine modulators (Imugene)

N/A

Report date: 2025/03/18 18:06:46
NME

Base Information

Drug Namearginine modulators (Imugene)
Drug Alias Namearginine modulators (Baker IDI)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionArginine modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBaker Idi Heart And Diabetes Institute Holdings Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImugene Ltd
Inactive CompaniesBaker Idi Heart And Diabetes Institute Holdings Ltd
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A